CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for H.U. Group Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

H.U. Group Holdings Inc
Akasaka Intercity AIR, 1-8-1, Akasaka
Phone: +81 362790801p:+81 362790801 MINATO-KU, TKY  107-0052  Japan Ticker: 45444544
Business Summary
H.U. Group Holdings Inc is a Japan-based company engaged in engages in businesses such as contracted clinical testing, the manufacture and sale of clinical testing reagents, and sterilization and surgery-related services. The Company operates through three business segments. The Testing and Related Services segment provides comprehensive testing services to medical institutions and includes clinical testing, outsourced health checkup services, and testing services for food, the environment, and cosmetics. The Clinical Testing Reagents segment manufactures and sells clinical testing reagents, including operations include the Lumipulse business, Contract Development and Manufacturing Organization (CDMO) and raw material supply businesses, and other products. The Healthcare-Related Services segment engages in sterilization and surgery-related businesses, as well as home-based services.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20263/31/2026Yes--YesYes

Industries
SIC Code Description
8071 Medical laboratories
2835 In vitro and in vivo diagnostic substances
7389 Business services, not elsewhere classified
8011 Offices and clinics of doctors of medicine
7359 Equipment rental and leasing, not elsewhere classified
6719 Offices of holding companies, not elsewhere classified
7352 Medical equipment rental and leasing
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Group Chief Executive Officer, Representative Executive Officer, Director GokiIshikawa 49 6/16/2026 6/1/2020
Managing Executive Officer, President of Subsidiary MakotoMatsumoto 57 6/17/2025 6/20/2023
Executive Officer, Chief Director of Human Resources and General Affairs TakayukiYoshizumi 57 6/17/2025 6/17/2025
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Fujirebio Holdings Inc. Akasaka Intercity AIR, 1-8-1 Akasaka Minato-ku Japan
Fujirebio Europe NV Technologiepark 6 Gent Belgium
Fujirebio Inc. 62-5, Nihonbashi-Hamacho 2-chome Tokyo Japan
3 additional Subsidiary records available in full report.

Business Names
Business Name
4544
Advanced Life Science Institute, Inc.
Baylor Miraca Genetics Laboratories LLC
21 additional Business Names available in full report.

General Information
Number of Employees: 5,157 (As of 3/31/2026)
Outstanding Shares: 55,070,836 (As of 9/30/2026)
Shareholders: 12,311
Stock Exchange: TYO
Fax Number: +81 359093336


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, November 8, 2026